A blood test can predict which patients with a type of cancer called diffuse large B cell lymphoma are likely to respond positively to initial therapy and which are likely to need more aggressive treatment, according to a ...
Aug 20, 2018
0
168
Research led by UCL has found that intensive and costly multisystemic therapy is no better than conventional therapy in treating teenagers with moderate to severe antisocial behaviour.
Jan 19, 2018
3
17
Patients have the right to decide what treatment, if any, they want to have. But it's incredibly important that the decisions people make are based on accurate information, allowing them to weigh up the pros and cons of the ...
Nov 2, 2017
0
1
(HealthDay)—For patients with chronic venous leg ulcers, autologous platelet-rich plasma (PRP) is safe and effective, with highly significant improvement in ulcer size compared to conventional treatment, according to a ...
Aug 29, 2017
0
2
We often see stories in the media about cancer patients who have chosen alternative treatments, either alongside or instead of conventional treatment.
Apr 28, 2015
1
54
Levels of interferon-stimulated genes in the liver and blood could help predict if a patient with hepatitis C will respond to conventional therapy, researchers at Kanazawa University suggest.
May 8, 2014
0
0
After a stroke, patients often struggle with persistent paresis. ETH researchers examined whether robot-assisted therapy can help stroke patients. This form of therapy proved successful particularly with the most severely ...
Jan 16, 2014
0
0
Patients with cancers of the head and neck who received intensity-modulated radiation therapy (IMRT) - a technology designed to more precisely target cancer cells and spare nearby tissue - experienced improved outcomes, as ...
Jan 13, 2014
0
1
The drug Belatacept, which the Medical University of Vienna – represented by Ferdinand Mühlbacher, Head of the University Department of Surgery and the immunologist Thomas Wekerle – was greatly involved in the development ...
Sep 10, 2013
0
1
Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. ...
Aug 21, 2013
1
2
